Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
22%
ALSO IN FMED
FMED
74
HOLDINGS
20%
ALSO IN XLV
SECTOR DRIFT (XLV minus FMED)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 5.6% | 2.3% | 2.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.7% | 2.2% | 2.2% |
|
DANAHER CORP | 2.2% | 3.2% | 2.2% |
|
INTUITIVE SURGICAL INC | 2.1% | 2.7% | 2.1% |
|
BOSTON SCIENTIFIC CORP | 1.2% | 1.3% | 1.2% |
XLV Overweight Relative to FMED
|
ELI LILLY & CO | 14.7% |
|
JOHNSON & JOHNSON | 10.3% |
|
ABBVIE INC | 7.4% |
|
MERCK & CO. INC. | 6.0% |
|
AMGEN INC | 3.8% |
|
UNITEDHEALTH GROUP INC | 3.3% |
|
ABBOTT LABORATORIES | 3.2% |
|
GILEAD SCIENCES INC | 2.9% |
|
PFIZER INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
XLV Underweight Relative to FMED
|
LIFESTANCE HEALTH GROUP, INC. | -4.8% |
|
10X GENOMICS INC CLASS A | -3.6% |
 |
UCB SA | -3.2% |
|
COGENT BIOSCIENCES INC | -2.7% |
|
ARGENX SE ADR | -2.6% |
|
ALNYLAM PHARMACEUTICALS INC | -2.5% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.3% |
|
BIO-TECHNE CORPORATION | -2.2% |
|
KYMERA THERAPEUTICS, INC. | -2.1% |
|
HEARTFLOW INC | -2.0% |